← All trials
NCT01861730
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2013
- Primary completion
- Dec 1, 2017
- Completion date
- Feb 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 243
- Arms / groups
- 7 / —
- Source
- AACT · pre-existing
Sponsors
- AerasLead sponsor
- AerasStudy director
- Statens Serum InstitutCollaborator
- National Institute of Allergy and Infectious Diseases (NIAID)Collaborator
- National Institute of Child Health and Human Development (NICHD)Collaborator
- Sanofi-AventisCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.